NCT Number: NCT00457262
Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women
paraoxonase 1 is involved to prevent LDL and HDL oxidation,so increase of it's activity leads to lower risk of coronary heart disease.In postmenopausal women ,we have decrease of paraoxonase1 activity and soy proteins may increase paraoxonase1 activity
Looking for future studies?
Notify MeKey information
Conditions
Age range
51 year–57 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
In a double blind clinical randomised clinical trial with parallel design this study was done.52 postmenopausal women were randomly assigned to 50 g/d soy protein or placebo for 10 weeks.serum lipoproteins and pon1 activity were measured at baseline and 10th week.There were significant increase in PON! activity and significant decrease in LDL-C,LDL-C/HDL-C,TC/HDL-C and TG/HDL-C in soy group compare to placebo group.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Cessation of menes for more than 1 year, elevation for more than 1 year
- Elevation of FSH level
- Total cholesterol
- Triglyceride more than 200 mg/dl
Exclusion criteria
- Chronic disease (heart disease, cancer, diabetes, hepatic, kidney and thyroid disease)
- Antihypertensive drugs
- Antibiotics
- Lipid lowering drugs
- Sex hormone treatment
- Hysterectomy
- Diet rich in soy protein
Treatment and study plan
Primary outcomes
-
decrease of LDL,increase of HDL,increase of paraoxonase 1
Sponsors and collaborators
Lead sponsor
Iran University of Medical Sciences
Other
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Apr 6, 2007
- Registry last updated
- Apr 6, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NCT03180294
Adnexal Diseases, Breast Carcinoma
Anaheim, California, United States
View Trial DetailsCardiovascular Adaptations to Resistance Exercise: Effect of Set Configuration on Postmenopausal Women
NCT05544357
Cardiovascular Diseases, Hypertension
Bastiagueiro, A Coruña, Spain
View Trial DetailsOnline Physical Activity Intervention for Peri- and Post-menopausal Working Women
NCT06821841
Perimenopausal Women, Postmenopausal
Royal Tunbridge Wells, Kent, United Kingdom
View Trial DetailsAlisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
NCT02860000
Breast Diseases, Breast Neoplasms
Washington D.C., District of Columbia, United States
View Trial Details